Introduction
WINDOX-CV Tablets deliver a potent antibiotic combination of Cefpodoxime Proxetil 200 mg and Potassium Clavulanate (eq. to Clavulanic Acid) 125 mg. The beta-lactamase inhibitor Clavulanic Acid protects Cefpodoxime from enzymatic degradation, extending its spectrum against resistant bacterial strains. Pack: 10×10 film-coated tablets.
Composition
Each WINDOX-CV film-coated tablet contains:
| Ingredient | Quantity |
|---|---|
| Cefpodoxime Proxetil IP eq. to Cefpodoxime | 200 mg |
| Potassium Clavulanate Diluted IP eq. to Clavulanic Acid | 125 mg |
| Excipients | q.s. |
| Color: Titanium Dioxide IP |
Benefits of WINDOX-CV Tab
- Enhanced Efficacy: The combination of Cefpodoxime and Clavulenic Acid provides a broader spectrum of activity and reduces the risk of bacterial resistance.
- Reliable Quality: Manufactured under stringent quality controls to ensure safety and efficacy.
- Convenient Dosage: Easy-to-follow dosage regimen for improved patient compliance.
How WINDOX-CV Works
Cefpodoxime inhibits bacterial cell wall synthesis (PBP binding), leading to bacterial death. Clavulanic Acid irreversibly binds beta-lactamase enzymes produced by resistant bacteria, preventing them from destroying Cefpodoxime and restoring its antibacterial efficacy.
Indications
- Upper and lower respiratory tract infections
- Urinary tract infections
- Skin and soft tissue infections
- Otitis media and sinusitis caused by beta-lactamase producing organisms
Recommended Usage
As directed by the physician. SCHEDULE HI — Prescription drug.
Precautions
- Consult your doctor before use if you have known allergies to cephalosporins or penicillins.
- Complete the full prescribed course even if symptoms improve.
- Report any allergic reactions or GI disturbances to your healthcare provider immediately.
- Not to be sold by retail without prescription of a Registered Medical Practitioner.